How to begin and develop a career in Technical Sales

As part of our biotechnology campaign Sarah Farrow a Scientific Recruiter who specialises in the biotechnology field speaks about how to begin and develop a career in Technical Sales.

Technical Sales jobs in the biotechnology industry can be fantastic as it gets you out of the office, enables you to utilise your technical expertise, and has some of the best earning potential in the industry.

Sarah in this video speaks about why technical sales is a great job, where most of the biotech companies are located and what employers are looking for in a potential employee. She also speaks about what is involved in Technical Sales role.

 

Watch this video here

 

Find out more about our campaign and other featured sectors here

 

 

 

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , ,

How to build a career in the stem cell sector

Have you ever considered a career in the stem cell sector of the biotechnology industry? Stem cell is a truly exciting area where many companies are receiving funding and are investing in.

As part of our Biotechnology campaign, Jason Johal speaks in this video about why the stem cell sector is a brilliant area to work in. He also gives you tips and advice on how to build a career in the stem cell sector, where the majority of businesses are located and the types of skills employers are looking for.

 

Watch Jason’s short video here

 

To find out more about this campaign or other sectors of the biotechnology industry click here

 

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , ,

CK Science launch biotech campaign

This month CK Science is focussing on careers in the Biotechnology sector by launching a mini, video-led campaign aimed at graduates and recent entrants into the industry. Our aim is to give a better understanding of the careers available in the industry, and the skills most employers need.

The growth of biotechnology in the UK has been phenomenal and in recent years we have noticed a dramatic uplift in the demand for biotech professionals. This is largely due to a large number of biotech businesses emerging to explore new and innovative therapies. As a recruitment consultancy specialising in the scientific industry we are uniquely positioned to identify employment trends and skills shortages so feel we can share our expertise and knowledge with those that need it most.

Click here to visit our biotech campaign site

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Cambridge Science Park Acquired by US Giant

As reported by Business Weekly, the US real estate investment company, BioMed Realty Trust, has acquired Granta Park, a leading science park based in Cambridge for £126.8m.

Currently, the Cambridge-based Science Park as 11 lab and office buildings and it’s tenants include some of the worlds leading pharma and biotech organisations including Gilead Sciences, UCB and Vernalis. The investment from BioMed Realty will also current tenant relationships with companies such as MedImmune and Pfizer to be extended.

Speaking of the agreement, BioMed Realty stated, “The Cambridge UK research community is anchored by the University of Cambridge, established in 1209, with 20 per cent of the world’s Nobel Prize recipients in medicine and chemistry and the recipient of over 280 million pounds in research grants in 2011.

“This Cambridge science cluster supports over 1,000 science and technology companies, the Wellcome Trust, the largest medical research charitable organisation in the world, Cavendish Laboratory, and the Babraham Institute.”Cambridge Science Park Acquired by US Giant

Looking for a new position in the Pharmaceutical or Biotechnology industries?

Click here to search and apply for Biotechnology jobs.

Click here to search and apply for Pharmaceutical jobs

Posted in Jobs, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , ,

Amgen acquires kidney drug biopharmaceutical company

As reported by The Pharma Times, the leading Biotechnology company, Amgen is acquiring KAI Pharmaceuticals, a biopharmaceutical company who has developed a novel drug  for chronic kidney disease.

Amgen have acquired KAI Pharmaceuticals for $315 million in cash which has given them rights to the experimental treatment for chronic kidney disease.

The kidney drug, called KAI-4169 is in Phase II and is being researched for the treatment of secondary hyperparathyroidism (SHPT) in those patients who are suffering with chronic kidney disease and are on dialysis. It is a drug that is administered intravenously.

The world’s largest biotech company, Amgen has given a loan to KAI to enable the Phase III trials to take place. The acquisition of KAI Pharmaceuticals will add to their already established dialysis drug portfolio (if it is approved). Amgen already have a drug used for the treatment of SHPT called Sensipar which is an oral drug.

Are you looking for a job in the Biotechnology Industry? Click here to search our current Biotech jobs online now.

Posted in Jobs, NewsTagged in , , , , , , , , ,